Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
Genotyping mice at 55% EBITDA - Acquisitions Anonymous 272
In this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in...
Let us know if you enjoyed this episodeIn this episode of Acquisitions Anonymous, Michael and Heather discuss an investment opportunity in a genomic testing , specializing in DNA sequencing and genotyping for mice. Despite their initial unfamiliarity with the technical details, they recognize the company's significant role in pharmaceutical research. They are impressed by its financial performance, noting substantial growth in revenue and EBITDA, along with high margins. The conversation also...
Episode Transcript
More Episodes
The $10M “AI Anti-Aging Bed” That Might Be Too Weird to Be Real
In this episode the hosts analyze a bizarre AI-powered therapeutic bed business with strong profits but questionable positioning, confusing pricing, and a whiff of pseudo-science risk.
This Franchise Cleans Fryer Oil… But Is It Profitable?
In this episode the hosts debate a commercial kitchen oil filtration franchise that most liked for its recurring revenue potential, while one host strongly opposed it due to small market size, customer churn risk, and dependence on struggling restaurants.
Would You Buy This Healthcare SaaS? (Birth Tracking App)
In this episode the hosts analyze a tiny niche SaaS serving midwives and doulas with 80% margins but conclude the $400K price is too high given zero growth, easy replication risk, and limited market traction.